Form D · Biotechnology

Stemina Biomarker Discovery, Inc.

Madison, WI · CIK 0001408083

Offering snapshot reported Jun 7, 2016 · SEC filing

Reported sold
$1M
Offering amount: $1.1M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 23, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 7, 2016Initial$1,000,417No comparison1SEC filing
Jun 7, 2016Amendment$4,251,178$1,648,991vs Jan 13, 201529SEC filing
Jan 13, 2015Initial$2,602,187No comparison21SEC filing
Jul 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-264499

Source: Form D, filed Jun 7, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert E. Burrier Executive
Scott Carr Director
Elizabeth L.R. Donley Director, Executive
Andrew Ferrara Director
Kevin Krenitsky Director
Judith K. Marquis Director
R. Andrew Morgan Director
Marc Schneebaum Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
504 S Rosa Road Suite 150
Madison, WI, 53719